During viral entry, MXSGD targeted viral entry by disrupting the viral surface, inhibited IAV surface glycoprotein neuraminidase (NA) activity, and regulated phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling against the infection [19, 20]. The gene discussed is AKT1; the disease is infection.